Epidemiological data of ovarian cancer in Vojvodina and south great plain region in Hungary in 2007-2012 period: CrossBiomark IPA PROJECT HUSRB/1203/214/091
Background: Ovarian cancer is among the sixth leading cancers in Vojvodina and the fifth leading cause of cancer death among female population in Vojvodina according to Cancer Registry of Vojvodina in 2010. The majority of ovarian cancers cases are diagnosed at an advanced stage, FIGO stage III-IV w...
Gespeichert in:
Veröffentlicht in: | Archive of oncology 2013, Vol.21 (3-4), p.97-100 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background: Ovarian cancer is among the sixth leading cancers in Vojvodina
and the fifth leading cause of cancer death among female population in
Vojvodina according to Cancer Registry of Vojvodina in 2010. The majority of
ovarian cancers cases are diagnosed at an advanced stage, FIGO stage III-IV
with poor prognosis. The aim of the study was to evaluate newly diagnosed
ovarian cancer among female population in Vojvodina (Serbia) and South Great
Plain region in Hungary in 2007- 2012 period. Methods: The evaluation was
based on the data from hospital registries for malignant diseases at the
Oncology Institute of Vojvodina and the Department of Oncotherapy, University
of Szeged. Results: The majority of patients were diagnosed in advanced
disease (FIGO stage III-IV) in both regions. Serous epithelial ovarian cancer
was the most common cancer type among studied women in both regions. The
average age of women diagnosed with ovarian cancer was 60 years; there was no
significant statistical difference related to patients? age in both studied
regions. Advanced stage of ovarian cancer investigated in our study showed a
moderate descending liner trend with no significant statistical difference.
The results from our study were similar when compared with the
epidemiological data from the literature. Conclusion: The lack of efficient
screening methods is the major obstacle to improve the prognosis of women
affected by this disease. Further investigations and introduction of new
technologies applied to medical discoveries offers new hope for finding
effective screening policies.
nema |
---|---|
ISSN: | 0354-7310 1450-9520 |
DOI: | 10.2298/AOO1304097M |